Trimbow inhalation powder

Trimbow is a pharmaceutical product used for the maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD) and asthma. It is a triple-combination therapy containing beclometasone, formoterol, and glycopyrronium.

The brand originated in Italy under Chiesi Farmaceutici S.p.A., a family-owned international research-focused pharmaceutical group. While Chiesi has manufacturing facilities across Europe, including France and Brazil, the primary production of their respiratory products typically occurs at their specialized plants in Italy. The ultimate owner remains the Chiesi family through their global corporate structure centered in Parma, Italy.